Manisha Singh

5PUBLICATIONS
6CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 10, 2025
IL-1R1 Blockade Boosts CD40 Agonist Immune Responses but Fails to Improve Efficacy or Reduce Hepatotoxicity in Pancreatic Cancer.

Akash Boda, Irfan N Bandey, Saikat Chowdhury

|Mar 30, 2023
Therapeutic Vaccination in Head and Neck Squamous Cell Carcinoma-A Review.

K Devaraja, Sadhna Aggarwal, Manisha Singh

|Dec 03, 2021
Improving cancer immunotherapy by targeting IL-1.

Zhilan Xiao, Shubhra Singh, Manisha Singh

|Mar 16, 2021
IL-1α Mediates Innate and Acquired Resistance to Immunotherapy in Melanoma.

Shubhra Singh, Zhilan Xiao, Karishma Bavisi

Pageof 1